These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

281 related articles for article (PubMed ID: 34322373)

  • 1. Psoriasis and Cardiometabolic Diseases: The Impact of Inflammation on Vascular Health.
    Teklu M; Parel PM; Mehta NN
    Psoriasis (Auckl); 2021; 11():99-108. PubMed ID: 34322373
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Psoriasis and Cardiovascular Comorbidities: Focusing on Severe Vascular Events, Cardiovascular Risk Factors and Implications for Treatment.
    Hu SC; Lan CE
    Int J Mol Sci; 2017 Oct; 18(10):. PubMed ID: 29065479
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Psoriasis and metabolic syndrome.
    Sales R; Torres T
    Acta Dermatovenerol Croat; 2014; 22(3):169-74. PubMed ID: 25230056
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Psoriasis and cardiovascular disorders.
    Frieder J; Ryan C
    G Ital Dermatol Venereol; 2016 Dec; 151(6):678-693. PubMed ID: 27627099
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Metabolic disorders in patients with psoriasis].
    Sikora-Grabka E; Adamczak M; Wiecek A
    Przegl Lek; 2011; 68(12):1193-8. PubMed ID: 22519279
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A study of cardio-metabolic risk profile in patients with psoriasis.
    Karoli R; Fatima J; Shukla V; Dhillon KS; Khanduri S; Maini S; Chandra A
    J Assoc Physicians India; 2013 Nov; 61(11):798-803. PubMed ID: 24974491
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Systemic inflammation and imbalance between endothelial injury and repair in patients with psoriasis are associated with preclinical atherosclerosis.
    Pirro M; Stingeni L; Vaudo G; Mannarino MR; Ministrini S; Vonella M; Hansel K; Bagaglia F; Alaeddin A; Lisi P; Mannarino E
    Eur J Prev Cardiol; 2015 Aug; 22(8):1027-35. PubMed ID: 24906366
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Catastrophic stroke burden in a patient with uncontrolled psoriasis and psoriatic arthritis: a case report.
    Fan JM; Solomon DA; López GY; Hofmann JW; Colorado RA; Kim AS; Meisel K; Halabi C
    BMC Neurol; 2020 Mar; 20(1):106. PubMed ID: 32199449
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevalence of smoking, alcohol consumption and metabolic syndrome in patients with psoriasis.
    Adışen E; Uzun S; Erduran F; Gürer MA
    An Bras Dermatol; 2018 Mar; 93(2):205-211. PubMed ID: 29723384
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cardiometabolic Comorbidities in Psoriasis and Psoriatic Arthritis.
    Puig L
    Int J Mol Sci; 2017 Dec; 19(1):. PubMed ID: 29295598
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Complement C3 as a marker of cardiometabolic risk in psoriasis.
    Torres T; Bettencourt N; Mendonça D; Vasconcelos C; Silva BM; Selores M
    Arch Dermatol Res; 2014 Sep; 306(7):653-60. PubMed ID: 24848273
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Psoriasis and Vascular Risk : An Update.
    Katsiki N; Anagnostis P; Athyros VG; Karagiannis A; Mikhailidis DP
    Curr Pharm Des; 2014; 20(39):6114-25. PubMed ID: 24745923
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Psoriasis and cardiovascular disease].
    Torres T; Sales R; Vasconcelos C; Selores M
    Acta Med Port; 2013; 26(5):601-7. PubMed ID: 24192101
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cardiometabolic comorbidities and the approach to patients with psoriasis.
    Gisondi P; Girolomoni G
    Actas Dermosifiliogr; 2009 Dec; 100 Suppl 2():14-21. PubMed ID: 20096157
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cardiometabolic Comorbidities in Patients With Psoriasis: Focusing on Risk, Biological Therapy, and Pathogenesis.
    Cai J; Cui L; Wang Y; Li Y; Zhang X; Shi Y
    Front Pharmacol; 2021; 12():774808. PubMed ID: 34803716
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Psoriasis and the metabolic syndrome.
    Gottlieb AB; Dann F; Menter A
    J Drugs Dermatol; 2008 Jun; 7(6):563-72. PubMed ID: 18561588
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inflammation in atherosclerosis and psoriasis: common pathogenic mechanisms and the potential for an integrated treatment approach.
    Späh F
    Br J Dermatol; 2008 Aug; 159 Suppl 2():10-7. PubMed ID: 18700910
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chronic skin inflammation accelerates macrophage cholesterol crystal formation and atherosclerosis.
    Baumer Y; Ng Q; Sanda GE; Dey AK; Teague HL; Sorokin AV; Dagur PK; Silverman JI; Harrington CL; Rodante JA; Rose SM; Varghese NJ; Belur AD; Goyal A; Gelfand JM; Springer DA; Bleck CK; Thomas CL; Yu ZX; Winge MC; Kruth HS; Marinkovich MP; Joshi AA; Playford MP; Mehta NN
    JCI Insight; 2018 Jan; 3(1):. PubMed ID: 29321372
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Links and risks associated with psoriasis and metabolic syndrome.
    Liakou AI; Zouboulis CC
    Psoriasis (Auckl); 2015; 5():125-128. PubMed ID: 29387589
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Psoriasis and the metabolic syndrome.
    Alsufyani MA; Golant AK; Lebwohl M
    Dermatol Ther; 2010; 23(2):137-43. PubMed ID: 20415820
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.